Royal Bank of Canada Lowers Biohaven Price Target to 58.00
| SSYGX Fund | USD 43.01 0.15 0.35% |
Slightly above 52% of Dreyfus/the Boston's investor base is interested to short. The analysis of overall sentiment of trading Dreyfusthe Boston Pany mutual fund suggests that many investors are impartial at this time. Dreyfus/the Boston's investing sentiment can be driven by a variety of factors including economic data, Dreyfus/the Boston's earnings reports, geopolitical events, and overall market trends.
Dreyfus/the |
Biohaven had its price target dropped by research analysts at Royal Bank of Canada from 66.00 to 58.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Royal Bank of Canadas target price indicates a potential upside of 24.30 percent from the companys
Read at thelincolnianonline.com
 |
Dreyfus/the Boston Fundamental Analysis
We analyze Dreyfus/the Boston's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus/the Boston using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus/the Boston based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Dreyfusthe Boston is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Dreyfusthe Boston Pany Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus/the Boston mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus/the Boston could also be used in its relative valuation, which is a method of valuing Dreyfus/the Boston by comparing valuation metrics with similar companies.
Peers
Dreyfus/the Boston Related Equities
| RYHCX | Health Care | 0.63 | ||||
| RAGHX | Allianzgi Health | 0.38 | ||||
| GGHYX | Invesco Global | 0.22 | ||||
| FHCCX | Fidelity Advisor | 0.14 | ||||
| ETAHX | Eventide Healthcare | 0.17 |
Other Information on Investing in Dreyfus/the Mutual Fund
Dreyfus/the Boston financial ratios help investors to determine whether Dreyfus/the Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus/the with respect to the benefits of owning Dreyfus/the Boston security.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |